You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/11288
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZornoff, Leonardo Antonio Mamede-
dc.contributor.authorPaiva, Sergio Alberto Rupp de-
dc.contributor.authorAssalin, Vanessa M.-
dc.contributor.authorPola, Patrícia M. S.-
dc.contributor.authorBecker, Luís E.-
dc.contributor.authorOkoshi, Marina Politi-
dc.contributor.authorMatsubara, Luiz Shiguero-
dc.contributor.authorInoue, Roberto M. T.-
dc.contributor.authorSpadaro, Joel-
dc.date.accessioned2014-05-20T13:33:01Z-
dc.date.available2014-05-20T13:33:01Z-
dc.date.issued2002-04-01-
dc.identifierhttp://dx.doi.org/10.1590/S0066-782X2002000400007-
dc.identifier.citationArquivos Brasileiros de Cardiologia. Sociedade Brasileira de Cardiologia - SBC, v. 78, n. 4, p. 401-405, 2002.-
dc.identifier.issn0066-782X-
dc.identifier.urihttp://hdl.handle.net/11449/11288-
dc.description.abstractOBJECTIVE: To evaluate clinical profiles, predictors of 30-day mortality, and the adherence to international recommendations for the treatment of myocardial infarction in an academic medical center hospital. METHODS: We retrospectively studied 172 patients with acute myocardial infarction, admitted in the intensive care unit from January 1992 to December 1997. RESULTS: Most patients were male (68%), white (97%), and over 60 years old (59%). The main risk factor for coronary atherosclerotic disease was systemic blood hypertension (63%). Among all the variables studied, reperfusion therapy, smoking, hypertension, cardiogenic shock, and age were the predictors of 30-day mortality. Most commonly used medications were: acetylsalicylic acid (71%), nitrates (61%), diuretics (51%), angiotensin-converting enzyme inhibitors (46%), thrombolytic therapy (39%), and beta-blockers (35%). CONCLUSION: The absence of reperfusion therapy, smoking status, hypertension, cardiogenic shock, and advanced age are predictors of 30-day mortality in patients with acute myocardial infarction. In addition, some medications that are undoubtedly beneficial have been under-used after acute myocardial infarction.en
dc.format.extent401-405-
dc.language.isoeng-
dc.publisherSociedade Brasileira de Cardiologia (SBC)-
dc.sourceSciELO-
dc.subjectmyocardial infarctionen
dc.subjectmortalityen
dc.subjecttreatmenten
dc.titleClinical Profile, Predictors of Mortality, and Treatment of Patients after Myocardial Infarction, in an Academic Medical Center Hospitalen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationUniversidade Estadual Paulista Faculdade de Medicina de Botucatu-
dc.description.affiliationUnespUniversidade Estadual Paulista Faculdade de Medicina de Botucatu-
dc.identifier.doi10.1590/S0066-782X2002000400007-
dc.identifier.scieloS0066-782X2002000400007-
dc.rights.accessRightsAcesso aberto-
dc.identifier.fileS0066-782X2002000400007.pdf-
dc.relation.ispartofArquivos Brasileiros de Cardiologia-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.